Literature DB >> 16617320

G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent.

R Tonelli, R Sartini, R Fronza, F Freccero, M Franzoni, D Dongiovanni, M Ballarini, S Ferrari, M D'Apolito, G Di Cola, G Capranico, A Khobta, R Campanini, P Paolucci, S Minucci, A Pession.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16617320     DOI： 10.1038/sj.leu.2404221

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  The genomics of acute myeloid leukemia in children.

Authors:  Shannon E Conneely; Rachel E Rau
Journal:  Cancer Metastasis Rev       Date:  2020-03       Impact factor: 9.264

Review 2.  The role of HDACs inhibitors in childhood and adolescence acute leukemias.

Authors:  Riccardo Masetti; Salvatore Serravalle; Carlotta Biagi; Andrea Pession
Journal:  J Biomed Biotechnol       Date:  2011-01-13

Review 3.  Therapeutic targeting of MLL.

Authors:  Michaela Liedtke; Michael L Cleary
Journal:  Blood       Date:  2009-03-16       Impact factor: 22.113

4.  In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase.

Authors:  Laura Mezzanotte; Raffaella Fazzina; Elisa Michelini; Roberto Tonelli; Andrea Pession; Bruce Branchini; Aldo Roda
Journal:  Mol Imaging Biol       Date:  2009-11-25       Impact factor: 3.488

Review 5.  Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.

Authors:  Michael Dickinson; Ricky W Johnstone; H Miles Prince
Journal:  Invest New Drugs       Date:  2010-12-14       Impact factor: 3.850

6.  Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia.

Authors:  Nicolas Bonadies; Samuel D Foster; Wai-In Chan; Brynn T Kvinlaug; Dominik Spensberger; Mark A Dawson; Elaine Spooncer; Anthony D Whetton; Andrew J Bannister; Brian J Huntly; Berthold Göttgens
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 7.  MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.

Authors:  Amanda C Winters; Kathrin M Bernt
Journal:  Front Pediatr       Date:  2017-02-09       Impact factor: 3.418

8.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

9.  Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy.

Authors:  M V Stankov; M El Khatib; B Kumar Thakur; K Heitmann; D Panayotova-Dimitrova; J Schoening; J P Bourquin; N Schweitzer; M Leverkus; K Welte; D Reinhardt; Z Li; S H Orkin; G M N Behrens; J H Klusmann
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

10.  Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia.

Authors:  Calum Leitch; Tereza Osdal; Vibeke Andresen; Maren Molland; Silje Kristiansen; Xuan Nhi Nguyen; Øystein Bruserud; Bjørn Tore Gjertsen; Emmet McCormack
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.